NasdaqCM - Nasdaq Real Time Price USD
Tharimmune, Inc. (THAR)
1.5100
+0.0200
+(1.34%)
At close: May 9 at 4:00:00 PM EDT
1.5100
0.00
(0.00%)
After hours: May 9 at 6:53:09 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 29.8k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MILBY RANDY Chief Executive Officer | Purchase at price 2.12 per share. | Direct | 9,752 | Dec 19, 2024 |
| APPAJOSYULA SIREESH Chief Operating Officer | Purchase at price 2.02 per share. | Direct | 10,096 | Nov 13, 2024 |
| MILBY RANDY Chief Executive Officer | Purchase at price 2.08 - 2.10 per share. | Direct | 5,221 | Oct 8, 2024 |
| APPAJOSYULA SIREESH Chief Operating Officer | Purchase at price 1.93 per share. | Direct | 9,650 | Oct 8, 2024 |
| APPAJOSYULA SIREESH Chief Operating Officer | Purchase at price 1.93 per share. | Direct | 9,650 | Oct 8, 2024 |
| MILBY RANDY Chief Executive Officer | Purchase at price 0.50 per share. | Direct | 14,587 | Dec 15, 2023 |
| MILBY RANDY Chief Executive Officer | Purchase at price 1.00 per share. | Direct | 10,000 | Nov 30, 2023 |
Related Tickers
ATNF 180 Life Sciences Corp.
1.0900
-0.91%
RPTX Repare Therapeutics Inc.
1.3600
0.00%
MTVA MetaVia Inc.
0.7290
+3.21%
PTIX Protagenic Therapeutics, Inc.
3.1100
-11.14%
TELO Telomir Pharmaceuticals, Inc.
2.4900
-1.19%
CYCC Cyclacel Pharmaceuticals, Inc.
0.2534
-15.53%
PCSA Processa Pharmaceuticals, Inc.
0.2390
-12.77%
ONCO Onconetix, Inc.
0.0720
-1.10%
TNFA TNF Pharmaceuticals, Inc.
0.1900
-3.36%
IMNN Imunon, Inc.
0.8000
-3.73%